Inventor · disambiguated record
David A. Mareska
Also filed as: MARESKA DAVID A
24 granted patents·6 pending applications·700 citations·filing 2003–2025
95Inventor score
Files withKNOPP BIOSCIENCES LLC11BIOHAVEN THERAPEUTICS LTD7ARRAY BIOPHARMA INC6AMGEN INC2AICHER THOMAS DANIEL1
Top patents by PatentIndex Score
30 records- 0196US11724990B2Kv7 channel activators compositions and methods of useKNOPP BIOSCIENCES LLC·Filed 2022·Granted Aug 15, 2023·4 cites·14 claims
- 0296US11261162B2KV7 channel activators compositions and methods of useKNOPP BIOSCIENCES LLC·Filed 2020·Granted Mar 1, 2022·3 cites·20 claims
- 0396US7799782B2P38 inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2009·Granted Sep 21, 2010·600 cites·23 claims
- 0495US10851067B2Kv7 channel activators compositions and methods of useKNOPP BIOSCIENCES LLC·Filed 2019·Granted Dec 1, 2020·6 cites·28 claims
- 0595US9481653B2Benzoimidazol-1,2-yl amides as Kv7 channel activatorsKNOPP BIOSCIENCES LLC·Filed 2015·Granted Nov 1, 2016·15 cites·19 claims
- 0693US9914708B2Benzoimidazol-1,2-yl amides as Kv7 channel activatorsKNOPP BIOSCIENCES LLC·Filed 2016·Granted Mar 13, 2018·10 cites·16 claims
- 0792US10385025B2Benzoimidazol-1,2-yl amides as Kv7 channel activatorsKNOPP BIOSCIENCES LLC·Filed 2018·Granted Aug 20, 2019·9 cites·16 claims
- 0892US10106536B2Imidazo(4,5-B) pyridin-2-yl amides as KV7 channel activatorsKNOPP BIOSCIENCES LLC·Filed 2017·Granted Oct 23, 2018·5 cites·12 claims
- 0991US9650376B2Imidazo(4,5-B) pyridin-2-yl amides as KV7 channel activatorsKNOPP BIOSCIENCES LLC·Filed 2014·Granted May 16, 2017·8 cites·23 claims
- 1088US12351559B2Benzoimidazol benzomidazol-1,2-yl amides as Kv7 channel activatorsBIOHAVEN THERAPEUTICS LTD·Filed 2023·Granted Jul 8, 2025·0 cites·16 claims
- 1185US7521447B2P38 inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2004·Granted Apr 21, 2009·28 cites·33 claims
- 1284US10906877B2Benzoimidazol-1,2-yl amides as Kv7 channel activatorsKNOPP BIOSCIENCES LLC·Filed 2019·Granted Feb 2, 2021·1 cites·8 claims
- 1383US12286408B2KV7 channel activators compositions and methods of useBIOHAVEN THERAPEUTICS LTD·Filed 2023·Granted Apr 29, 2025·0 cites·16 claims
- 1475US11834418B2Benzoimidazol-1,2-yl amides as Kv7 channel activatorsBIOHAVEN THERAPEUTICS LTD·Filed 2020·Granted Dec 5, 2023·0 cites·20 claims
- 1575US9174981B2Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitorsBOYS MARK LAURENCE·Filed 2011·Granted Nov 3, 2015·3 cites·30 claims
- 1673US8017641B2P38 inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2009·Granted Sep 13, 2011·1 cites·10 claims
- 1772US9809590B2Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2015·Granted Nov 7, 2017·1 cites·29 claims
- 1871US8518983B2P38 inhibitors and methods of use thereofMUNSON MARK·Filed 2009·Granted Aug 27, 2013·2 cites·8 claims
- 1971US2025171429A1Pyrazolyl compounds as kv7 channel activatorsBIOHAVEN THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 2068US10526328B2Imidazo[4,5-b]pyridin-2-yl amides as Kv7 channel activatorsKNOPP BIOSCIENCES LLC·Filed 2018·Granted Jan 7, 2020·0 cites·1 claims
- 2167US10669269B2Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Jun 2, 2020·0 cites·16 claims
- 2266US8809538B2Piperidine-containing compounds and use thereofRODRIGUEZ MARTHA E·Filed 2010·Granted Aug 19, 2014·2 cites·6 claims
- 2366US2025230152A1Pyrazolyl compounds as kv7 channel activatorsBIOHAVEN THERAPEUTICS LTD·Filed 2025·Application pending·0 cites
- 2465US7425631B2Compounds and methods of useAMGEN INC·Filed 2004·Granted Sep 16, 2008·2 cites·6 claims
- 2563US2025171430A1Pyrazolyl compounds as kv7 channel activatorsBIOHAVEN THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 2661US2025066351A1Pyrazolo[1,5-a]pyridin-2,3-yl amides as kv7 channel activatorsBIOHAVEN THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 2757US2009048224A1Compounds and methods of useAMGEN INC·Filed 2008·Application pending·0 cites
- 2842US7078425B2Preparation of phosphatase inhibitorsARRAY BIOPHARMA INC·Filed 2003·Granted Jul 18, 2006·0 cites·15 claims
- 2940US2020062714A1BENZOIMIDAZOL-1,2-YL AMIDES AS Kv7 CHANNEL ACTIVATORSKNOPP BIOSCIENCES LLC·Filed 2017·Application pending·0 cites
- 3037US8754226B2Piperidinyl-substituted lactams as GPR119 modulatorsAICHER THOMAS DANIEL·Filed 2011·Granted Jun 17, 2014·0 cites·71 claims
Join the waitlist — get patent alerts
Get an alert when David A. Mareska files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →